International Journal of Environmental Research and Public Health Article Consensus Modeling for Prediction of Estrogenic Activity of Ingredients Commonly Used in Sunscreen Products Huixiao Hong 1,*,†, Diego Rua 2,*,†, Sugunadevi Sakkiah 1, Chandrabose Selvaraj 1, Weigong Ge 1 and Weida Tong 1 1 Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA;
[email protected] (S.S.);
[email protected] (C.S.);
[email protected] (W.G.);
[email protected] (W.T.) 2 Division of Nonprescription Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA * Correspondance:
[email protected] (H.H.);
[email protected] (D.R.); Tel.: +1-870-543-7296 (H.H.); +1-240-402-2454 (D.R.); Fax: +1-870-543-7854 (H.H.) † These authors contributed equally to this work. Academic Editor: Paul B. Tchounwou Received: 4 August 2016; Accepted: 20 September 2016; Published: 29 September 2016 Abstract: Sunscreen products are predominantly regulated as over-the-counter (OTC) drugs by the US FDA. The “active” ingredients function as ultraviolet filters. Once a sunscreen product is generally recognized as safe and effective (GRASE) via an OTC drug review process, new formulations using these ingredients do not require FDA review and approval, however, the majority of ingredients have never been tested to uncover any potential endocrine activity and their ability to interact with the estrogen receptor (ER) is unknown, despite the fact that this is a very extensively studied target related to endocrine activity.